Health systems are reevaluating their purchasing strategies as federal policy shifts, court decisions, and economic uncertainties introduce new financial pressures. We recently surveyed 59 health system purchasing leaders to better understand how they’re evolving their drug, medical device, and supply purchasing. We asked respondents about their plans to take 18 purchasing-related actions, ranging from reducing spend, to renegotiating with vendors, diversifying vendors, and more. Here are our four biggest takeaways.